Condition
Pleural Mesothelioma
Estimated Enrollment: 15
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: IRB15-1149
Study First Received: February 29, 2016
Last Updated: December 28, 2016
Estimated Primary Completion Date: March 2018
Primary Outcome Measures:
Gamma-Interferon Gene Expression profile (GEP) response rate defined as an increase beyond the median value of the sum of individual genes|Number of participants with adverse events as measured by CTCAEv4.0
Sponsors and Collaborators:
University of Chicago
Website Link: https://ClinicalTrials.gov/show/NCT02707666
